gsk376501
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00404963)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk376501
- gsk376501
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00605449 | Phase 1 | Jan 1, 2008 | GlaxoSmithKline |
| NCT00615212 | Phase 1 | Jan 1, 2008 | GlaxoSmithKline |
| NCT00495014 | Phase 1 | Jun 1, 2007 | GlaxoSmithKline |
| NCT00404963 | Phase 1 | Oct 1, 2006 | GlaxoSmithKline |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 4 | 4 | 1 | 2006 |
1 organizations
Page 1 / 1